Thrombus remodelling by reversible and irreversible P2Y 12 inhibitors

普拉格雷 P2Y12 替卡格雷 血小板 血栓 抗血栓 氯吡格雷 药理学 血小板活化 二磷酸腺苷 医学 化学 心脏病学 内科学 阿司匹林 血小板聚集
作者
Kjersti Tunströmer,Lars Faxälv,Pia Larsson,Tomas L. Lindahl,Niklas Boknäs
出处
期刊:Platelets [Informa]
卷期号:34 (1): 2157805-2157805 被引量:7
标识
DOI:10.1080/09537104.2022.2157805
摘要

Pharmacological inhibition of the platelet ADP-receptor P2Y12 is a cornerstone in the prevention of atherothrombotic events in adult patients with acute coronary syndrome (ACS). Thienopyridines such as clopidogrel and prasugrel exert their antithrombotic effect by means of active metabolites that irreversibly inhibit P2Y12. Due to the short half-life of these metabolites, a subpopulation of ADP-responsive platelets will form in between dosing. With increased platelet turnover rate or poor patient compliance, the fraction of ADP-responsive platelets will increase, potentially increasing the risk for new thrombotic events. In contrast, the reversible P2Y12 inhibition produced by direct-acting ADP blockers such as ticagrelor and cangrelor inhibit the entire platelet population. In this study, we evaluated the impact of these pharmacological differences on thrombus formation in an ex vivo flow chamber model. A customized image analysis pipeline was used for automatized, large-scale identification and tracking of single platelets incorporated into the thrombus, enabling quantitative analysis of the relative contribution of inhibited and uninhibited platelets to thrombus growth and consolidation. Comparative experiments were conducted using the irreversible and reversible P2Y12 inhibitors prasugrel active metabolite (PAM) and ticagrelor, respectively. Our results show that PAM inhibited thrombus platelet recruitment more gradually than ticagrelor, with a slower onset of inhibition. Further, we show that the presence of a small fraction (<10%) of uninhibited platelets did not abrogate the antithrombotic effect of PAM to any significant extent. Finally, we demonstrate a gradual enrichment of inhibited platelets in the thrombus shell due to selective recruitment of inhibited platelets to the thrombus periphery.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3的应助被Cutecutely采纳,获得10
刚刚
139完成签到 ,获得积分10
1秒前
英姑的应助被麦辣鸡翅采纳,获得10
1秒前
2秒前
烟花的应助被草莓夕夕采纳,获得10
2秒前
jww完成签到,获得积分10
2秒前
晴天完成签到,获得积分10
2秒前
蓝天的应助被qqq采纳,获得10
3秒前
小二郎的应助被辛勤的梦菲采纳,获得10
3秒前
3秒前
daomaihu完成签到,获得积分10
3秒前
orixero的应助被tt采纳,获得10
3秒前
YE发布了新的文献求助10
4秒前
天真从彤完成签到,获得积分10
4秒前
4秒前
欣喜的秋蝶完成签到,获得积分10
5秒前
5秒前
石木尧完成签到,获得积分10
6秒前
橘子香橙完成签到 ,获得积分10
6秒前
6秒前
科目三的应助被matine采纳,获得10
6秒前
可靠的马丁完成签到,获得积分10
7秒前
YU发布了新的文献求助10
7秒前
小马甲的应助被小杨梅采纳,获得10
8秒前
9秒前
葫芦完成签到,获得积分10
9秒前
TONG发布了新的文献求助10
10秒前
天生骄傲完成签到,获得积分10
10秒前
无花果的应助被小郑采纳,获得10
10秒前
kmoonkkk发布了新的文献求助10
10秒前
SHMILY414完成签到,获得积分10
11秒前
踏实的盼柳的应助被听雨采纳,获得20
11秒前
11秒前
陈民发布了新的文献求助10
11秒前
Akim的应助被坦率的夜玉采纳,获得10
11秒前
KissesU完成签到 ,获得积分10
11秒前
11秒前
过时的龙猫完成签到,获得积分10
12秒前
英姑的应助被科研通管家采纳,获得10
12秒前
zttszds发布了新的文献求助20
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153442
求助须知:如何正确求助?哪些是违规求助? 9550127
关于积分的说明 21696715
捐赠科研通 7741908
什么是DOI,文献DOI怎么找? 3425483
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469152